Actimed Therapeutics to present at upcoming Bio-Europe conference as one of 'Scrip’s 10 to watch'
London, UK – 22nd October 2020. Actimed Therapeutics, the clinical stage company focused on bringing innovation to the treatment of muscle wasting disorders, with a focus on cachexia, has been invited to present at the digital BIO-Europe conference between 26th and 29th October, as one of “Scrip’s 10 to watch” companies.
Scrip’s 10 to watch are chosen by the editors of Scrip magazine, the leading international publication serving the pharmaceutical and biotechnology industries. The nominated companies represent promising companies in drug discovery and development, and are selected to present at BIO-Europe Digital 2020.
At this event, Robin Bhattacherjee, CEO of Actimed Therapeutics will provide details on the company’s progress and mission to secure the first approved product for the treatment of cancer cachexia and transform care for cancer patients.